VIC Technology Venture Development Forms New Portfolio Company: Filtravate

Company co-founded with Reza Foudazi, PhD, developer of a platform membrane technology with broad applications in bioprocessing and industrial filtration.

Failing to fundraise can be the downfall of startups

Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...

An Interview with Darlene Boudreaux: CEO, Investor, and Entrepreneur

Can you tell us a little bit about your background and experience? I was a founder and CEO of a pharmaceutical manufacturing company, and then took over and grew a nonprofit medical technology incubator, helping others...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

Behind the Curtain with Biolocity | Guiding Medical Innovations to Market

Please start off by describing your current role with Biolocity and the organization’s unique model.  I am the Managing Director for Biolocity, which is a philanthropic, multi-institutional program that accelerates the...

White Paper: New Paradigms of Life Science Investing

For decades, only venture capital (VC) firms, and very rarely, angels were able to invest in start-up companies developing life science—therapeutics, medical devices, diagnostics, and related—innovation.  Anyone doing...

A Letter from our CEO

Welcome to the 20s! To my ears, 2020 sounds very futuristic – but we are living it. The pace of technological change continues to accelerate and have profound impact on all of us. VIC’s motto is Technology Solutions for...

Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development

Ask ten people how best to assess the value of a new technology, and you’ll likely get ten different answers. Google "opportunity assessment", and you will find hundreds of different templates, worksheets, and...

White Paper: Life Science Impact Investing and the Physician Entrepreneur

Why Is Life Science Impact Investing So Crucial For Physicians Today? A high paying role with a prestigious title in medicine is no longer enough. It’s not enough in many ways. The path of throwing yourself into...

VIC Partner Profile: An Interview With Nichole Mercier, Office Of Technology Management At Washington University

You are the Assistant Vice Chancellor & Managing Director for Technology Transfer at Washington University in St. Louis. Can you please tell us about your background and what drives your sense of purpose in technology...

FEATURED RESOURCES

News
VIC Technology Venture Development Forms New Portfolio Company: Filtravate
Reports
VIC 2019 Annual Report
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
Interview
An Interview with Nichole Mercier at Washington University
White Paper
Sourcing Quality Innovation Beyond the VC Hot Zones
Case Study
Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development
White Paper
New Paradigms of Life Science Investing
Interview
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
White Paper
Life Science Impact Investing and the Physician Entrepreneur
From The Corner Office
Akeso Biomedical Nears Commercial Sales Stage